AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Sabki, Head of the General Authority for Health Care, met with Dr Samah Al-Bagouri, Chairman of the Board of Directors of ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that Florida reached with Swiss generic drugmaker Sandoz, saying a key provision ...

However, the World Health Organization (WHO) warns of a global threat called antimicrobial resistance (AMR). (1) Bac ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

Ozempic currently costs about $218 per month in Canada, but once generic drugs are on the scene, the price is expected to be ...